Targeting of adenovirus (Ad)-encoded therapeutic genes to specific cell types has become a major goal in gene therapy. Redirecting the specificity of infection requires the abrogation of the natural interaction between the viral fiber and its cellular receptors (CAR) and the simultaneous introduction of a new binding specificity into the viral capsid. To abrogate the natural affinity of the fiber, we have mutated residues presumed to be directly or indirectly involved in CARbinding in the knob domain of the fiber protein. These residues are located in the AB loop (Ser408) and in the DG loop (Tyr491, Ala494, Ala503). The mutations Ser408Glu,
Introduction
Recombinant human adenoviruses (Ad) are potentially useful gene therapy vectors because of their ability to mediate the transfer of therapeutic genes to a wide variety of cells. 1, 2 However, in some applications such as the in vivo transfer to specific tissues or transfer of genes encoding immunomodulatory or toxic proteins in tumor cells, their broad tissue tropism becomes a disadvantage. [3] [4] [5] Control of the specificity of infection would limit gene delivery only to target tissues thereby decreasing the viral dose and thus generating a more favorable therapeutic index. Adenoviral infection is initiated by the formation of a high affinity complex between the C-terminal part of the fiber protein, termed knob, and a host cell membrane protein. For the majority of the adenovirus serotypes, this receptor has been identified as the coxsackie B virus and adenovirus receptor (CAR). 6, 7 The major histocompatibility complex (MHC) class I ␣ 2 domain has also been proposed as a high affinity primary receptor for adenovirus serotype C fibers. 8 However, recent data demonstrated discordance between MHC class I heavy chain expression and Ad susceptibility confirming a pre-eminent role of CAR in Ad tropism. 9, 10 Entry of the attached virion into the cell occurs subsequently by internalization Tyr491Asp, Ala494Asp and Ala503Asp did not prevent the incorporation of trimeric fibers in the viral capsid but led to loss of CAR binding in vitro. Infectivity of the mutant viruses could be restored in vitro by introducing a ligand at the Cterminal end of the knob, confirming that the reduced infectivity of the fiber-modified virus was due to an impaired interaction of the viral particle with the CAR receptor. However, after systemic delivery, the in vivo biodistribution of impaired CAR-binding viruses without addition of a specific ligand was not altered when compared with wild-type Ad. Gene Therapy (2001) 8, 49-57. into clathrin-coated vesicles and is mediated by the recognition of the Arg-Gly-Asp (RGD) sequence located in the viral penton base protein by cellular ␣ v ␤ 3 and ␣ v ␤ 5 integrins. 11, 12 Previous studies have demonstrated that the knob domain of Ad fiber proteins contains all the sequences required for receptor binding. 13, 14 Each knob monomer is organized as a sandwich structure comprising eight antiparallel ␤-strands. Four of the ␤-strands (C, B, A, J) constitute the V-sheet and face towards the virion. The four other ␤-strands (G, H, I, D) form the R-sheet and face the cellular receptor. The ␤-strands represent only 35% of the knob monomer structure; the remaining 65% comprise turns and loops connecting the ␤-strands. The loops with lengths between eight and 55 residues are labeled AB, CD, DE and FG (or DG), GH, HI and IJ. 15 The knob domain, which probably acts as the triggering signal for correct folding of the fiber, forms a three-blade propeller with a surface depression. 15, 16 Only recently, through sequence analysis and mutagenesis of the knob domain of the Ad5, has a conserved receptor-binding region been identified. [17] [18] [19] [20] [21] These authors demonstrated that the CARbinding site consists of residues from the AB loop, the B ␤-sheet and the DE loop, while the FG loop seems to play an indirect role in binding CAR. As this site is located on the side of the knob monomer, these findings imply that the trimeric knob could bind to three CAR molecules independently. 18 Bewley et al, 19 by analyzing the crystal structure of the CAR-recognizing Ad12 fiber knob complexed with the D1 domain of the CAR protein, confirmed that the AB loop of the fiber plays an essential role in the interaction with the cellular receptor. Another group also confirmed, by surface plasmon resonance and Gene Therapy cell-binding competition experiments with recombinant mutated Ad fibers, that residues located in the AB and the DE loops and in ␤-strand E and F are directly or indirectly in contact with the cellular receptor. 20, 21 In the present study, fiber residues involved in CAR binding were identified. We have studied the impact of mutations on receptor binding in a viral context and on the biochemical properties of the corresponding viruses. Furthermore, retargeting of the fiber-modified virus has been assessed in vitro by the addition of an alternative ligand at the C-terminal end of the knob. Finally, the biodistribution of such impaired CAR-binding viruses after systemic administration in mice was investigated.
Results

Generation of fiber-modified adenoviruses
To eliminate the natural tropism of adenovirus, we have introduced a series of mutations in surface-exposed AB, CD, DG, GH and IJ loops of the knob domain of the fiber protein (Table 1) . Since we had previously observed that deletion of the ␤-strand of the R-sheet or loop is detrimental to the quaternary structure of the knob, 22 most mutations were designed to contain single amino acid substitutions. Serotype C residues were replaced either by a negatively charged aspartic acid residue (Asp) or substituted by the homologous serotype B amino acids since viruses from this serotype are unable to bind CAR. 6, [22] [23] [24] The genetically modified fiber coding sequences were reintroduced in the full-length E1-deleted, ␤-galactosidase expressing Ad5 genome by homologous recombination in E. coli. 25 Transfection of these Ad5 genomes in 293 cells or in 293-fiber complementation (293-Fb) cells allowed us to generate all mutant recombinant adenoviruses. Primary viral stocks produced on 293-Fb cells were propagated on 293 cells in order to produce viral particles that encode the modified fiber. After purification and titration, all the viruses produced showed physical particle titers similar to the wild-type Ad-LacZ Fiber mutations were constructed by site-directed mutagenesis and reintroduced in the full-length viral genomes as described in the Methods section.
virus (approximatively 10 12 Particle ml; Table 2 ). The nucleotide sequence of the viral DNA was verified routinely in order to ensure that all viruses contain the appropriate mutation in the fiber coding sequence.
Binding of mutant viruses to the Ad5 cellular receptor All fiber-mutant viruses produced were evaluated for their ability to bind Ad5 fiber cellular receptors by a competition assay using soluble recombinant knob. Infection of 293 cells by the majority of the mutant viruses (Table  1) was almost fully prevented (between 80 and 90% of inhibition) by pre-incubating the cells with a saturating concentration of competitor knob protein (data not shown). For these viruses, the infection of the target cells still seemed to be exclusively mediated through an interaction of the modified fiber with the CAR suggesting that the corresponding fiber mutations have no significant adverse effects on CAR binding. Interestingly, seven mutant viruses were identified which were able to infect 293 cells in the presence of high concentrations of soluble knob (Figure 1 ), suggesting that the binding of the corresponding viruses to the CAR receptor was impaired. Through the entire manuscript, these mutants will be referred to as CAR-ablated viruses. The mutations are located in the AB loop (Ser408Glu) and in the DG loop (Tyr491Asp, Ala494Asp, Phe497Asp, Met498Asp, Pro499-Gly, Ala503Asp), consistent with the results recently obtained by others. 18, 19, 21 In addition, the modified Leu48-5Asp-fiber virus still efficiently infects cells through CAR binding (Figure 1) . Interestingly, the substitution of the same residue to a lysine (Leu485Lys) has been shown to abolish high-affinity binding of the modified protein to CAR. 21 This result can be explained by the observation that Leu485 of Ad5 is structurally equivalent to Ser497 of Ad12, which in the Ad12 knob-CAR context is in close proximity to a positively charged region of CAR. Therefore, it appears logical that introducing a positively charged lysine at position 485 abrogates CAR-binding, while an aspartate has less or no effect. This indicates that in order to inhibit the interaction with the Ad receptor not only the position of the residue in the fiber is important but also the nature of the amino acid side chain.
Incorporation of the modified fiber in adenovirus capsid
Infection of 293 cells by the mutated viruses in the presence of competing knob could be due either to a significant reduction of the modified fiber binding to CAR or to a total absence of the fiber protein in the capsid. 26 In order to discriminate between these two possibilities, the incorporation of the modified protein into the viral particles was studied by Western blot analysis using sera directed against the Ad5 knob (kindly provided by Dr Gerard) and against the penton base (kindly provided by Pr Boulanger) ( Figure 2 ). As expected, no signal could be Gene Therapy detected for the control fiber-deleted virus produced on 293 cells while a strong positive signal was observed for the wt Ad-LacZ virus ( Figure 2 ). Among the seven mutants studied, three did not yield a stoichiometric amount of fiber at the expected size (Phe497Asp, Met498-Asp, Pro499Gly) suggesting that the corresponding mutations have dramatic effects on the correct folding of the fiber protein and prevent its assembly in the capsid. As previously reported for the fiberless virus, the CARindependent entry pathway of these mutants in 293 cells can be explained by the interactions between the RGD motif of the viral penton base and the cellular ␣ v ␤ 3 or ␣ v ␤ 5 integrins. 26 The four remaining mutants (Ser408Glu, Tyr491Asp, Ala494Asp, Ala503Asp) incorporate the modified fiber protein in stoichiometric amounts in the viral capsid ( Figure 2 ) demonstrating that the CAR-independent entry of these viruses must be related to a reduction of their ability to bind the primary cellular receptor.
Properties of the CAR-ablated mutant viruses
To characterize more precisely these four Ad mutants (Ser408Glu, Tyr491Asp, Ala494Asp, Ala503Asp), we further analyzed their growth properties on 293 cells, their viral infectivity as well as the protein profile of purified particles. The growth kinetics showed that the propagation of the fiber-modified viruses was greatly reduced compared with Ad-LacZ, yielding 10-to 50-fold less infectious virions per cell at 72 h after infection ( Figure 3 ). Consistent with this observation, the titers of infectious mutant virus (IU/ml) after large-scale production were markedly reduced compared with the Ad- LacZ titers despite the fact that the total number of physical particles was similar to wild-type Ad (Table 2) . We previously observed this phenomenon with fiberless AdLacZ virus and have shown that the reduction of the infectivity was not only the consequence of its inability to bind CAR. Indeed, this reduced infectivity was also due to a later step impaired in the cell entry process and correlated with an incorrect maturation of several viral structural proteins. 26 To rule out the latter possibility in the present study, the protein profile of the genetically modified particles was analyzed. As shown in Figure 4 , the modified fiber proteins (IV) are present in the viral particle in stoichiometric amounts. In addition, while the fiber-deleted Ad-LacZ virus still contains pVI, pVII and pVIII protein precursors, indicative of an incomplete proteolytic processing, the four different fiber-modified viruses exhibit the same protein profile as the Ad-LacZ (Figure 4a ). In addition, in order to detect an impairment of fiber-modified viruses beyond cell entry, we compared the efficacy of infection of the wild-type, fiberless and mutant viruses on the CAR-negative cell line CHO. As shown in Figure 4b , the four mutants that incorporate a stoichiometric amount of fiber infect CHO target cells with the same efficiency as the wild-type virus. However, as previously reported, 26 the Ad-LacZ/Fb°as well as the 'fiberless-like' Ad-LacZ/Fb-Phe497Asp, do not efficiently infect the CAR-negative cell line.
Taken together, these observations suggest that neither the assembly nor the processing nor the efficiency of the infectious process beyond the CAR binding but only the infectivity of the mutant viruses on 293 cells was greatly reduced. This suggests that the low infectivity is the consequence of a reduced binding of the modified fiber to the CAR receptor.
Incorporation of an alternative ligand
In order to try to restore efficient binding to 293 cells we have constructed a recombinant adenovirus containing both the S408E mutation and an alternative ligand at the C-terminal extremity of the knob sequence. The selected ligand is a peptide composed of seven lysine residues (7K) which is known to confer to the modified virus the ability to efficiently bind heparan sulfate-containing glycoproteins on the surface of target cells. [27] [28] [29] [30] The growth characteristics of viruses carrying or not carrying the additional ligand have been compared using heparan sulfate-containing 293 cells (Figure 5a ). We thus demonstrated that the Ad/Fb-Ser408Glu-7K virus propagates as efficiently as the wild-type virus on 293 cells while the kinetic growth of the Ad-LacZ/Fb-Ser408Glu was significantly reduced (Figure 5a ). The insertion of the polylysine motif in the mutated fiber was also shown to restore a correct infectivity (ratio IU particle = 1/100) as compared with the Ad-LacZ virus (ratio IU particle = 1/40) ( Table 2) . Competition experiments using soluble specific competitors were performed to study the entry pathway of these viruses ( Figure 5b ). As expected, the cell entry of the wild-type adenovirus is strongly inhibited by soluble knob proteins and RGD peptides but not by the heparin competitor. The Ad/Fb-7K is still capable of efficiently infecting 293 cells in the presence of soluble knob or heparin. On the other hand, the competing heparin was shown to fully inhibit the infection of the Ad/Fb-Ser408Glu-7K. A partial inhibition of Ad/FbSer408Glu infection by soluble heparin in the culture 
(᭺), 293 cells infected with Ad-LacZ/Fb-Ser408Glu-7K; () 293 cells infected with Ad-LacZ/Fb-7K. This experiment was repeated three times. (b) Entry pathway: 293 cells were preincubated for 1 h at 4°C with either 10 g/ml of knob (black bars), 3 mg/ml of heparin (white bars), 4 mg/ml of RGD peptide (gray bars) or a combination of the three compounds (hatched bars). Ad-LacZ, Ad-LacZ/Fb°, Ad-LacZ/Fb-Ser408Glu, Ad-LacZ/Fb-Ser408Glu-7K or Ad-LacZ/Fb-7K were then added at a MOI of 0.1 IU per cell. Twenty-four hours after infection, the cells were lysed and the ␤-galactosidase activity of the supernatant was monitored using a chemiluminescent detection. Infection efficiency is expressed as the percentage of the ␤-galactosidase activity in the absence of competitor.
medium was also observed. This was unexpected but could be explained by the fact that heparan sulfate-glycosaminoglycans expressed on the cell surface may be involved in the binding of Ad5 to host cells. 31 Our results demonstrate that the combination of the Ser408Glu mutation in the AB loop and the addition of the polylysine ligand allows specific retargeting towards heparan sulfate proteoglycans in vitro.
Gene Therapy
Figure 6 In vivo distribution of the CAR-ablated mutant viruses after intravenous administration in mice. (a) Biodistribution of the fiber-modified viral genomes 48 h after intravenous administration in mice. C57Bl/6 mice were injected intravenously in the tail vein with buffer (Mock, one mouse) or with 10 11 particles of the wild-type (Ad-LacZ, nine mice), fiberless (Ad-LacZ/Fb°, nine mice) and the fiber-modified virus (Ad-LacZ/FbSer408Glu, nine mice). Animals were killed after 48 h and total DNA was extracted from different organs such as spleen, liver, heart and lung for quantitative PCR assays. To correct for differences in DNA recovery from samples, data are presented as ratio of Ad DNA copies to ␤-actin DNA copies. Mock experiment shows that the background of the Taqman analysis is equal to zero for each tissue. (b) LacZ activity in the liver of injected mice. Proteins were extracted from the liver and LacZ activity as well as protein content were measured as described in the Materials and methods section.
In vivo distribution of the CAR-ablated mutant viruses after systemic administration in mice To investigate the in vivo tissue distribution of systemic administered mutant Ad viruses in C57Bl/6 mice, we traced the viral DNA by using quantitative PCR. Nine animals per adenovirus were injected intravenously (i.v.) with 10 11 particles of Ad-LacZ, Ad-LacZ/Fb°or AdLacZ/Fb-Ser408Glu in the tail vein. Mice were killed after 48 h and total DNA was extracted from the spleen, the liver, the heart and the lung for PCR assays. In agreement with published data, [32] [33] [34] [35] [36] more than 75% of the wild-type Ad genome was observed in the liver but viral DNA was also detected at lower levels in the spleen, the lung and the heart (Figure 6a) . Levels of the fiberless virus DNA after i.v. injection are low (ranging from 0 to 4 × 10
−3
Ad copies/␤-actin copies) compared with wild-type AdLacZ suggesting that the fiberless particles could be unstable and degraded in the blood stream before they Gene Therapy can infect the organs. Alternatively, the fiberless particles could be sequestered in endosomes after entry in the infected cells (V Legrand, unpublished data). The in vivo biodistribution of the CAR-ablated Ad genomes was not significantly different from the wild-type Ad. Indeed, with the Ad-LacZ/Fb-Ser408Glu mutant, viral DNA was found predominantly (more than 70%) in the liver (Figure 6a ). In addition, as shown in Figure 6b , the level of ␤-gal expression of this mutant virus in the liver was not significantly different from the Ad-LacZ virus suggesting that other pathways of entry, such as the interaction between penton base and ␣ v integrins play an important role in adenovirus-mediated gene transfer in this organ. Similar viral biodistribution and transgene expression data have been obtained with the AdLacZ/Fb-Ala494Asp and the Ad-LacZ/Fb-Ala503Asp mutant viruses (data not shown). Taken together, these results indicate an absence of significant modification of CAR-ablated viruses biodistribution after i.v. administration compared with wild-type virus.
Discussion
Broad efforts have been made to redirect the binding of adenovirus to specific cellular receptors by displaying various ligands on the surface of the virus. However, specific and efficient targeting first requires the elimination of the natural binding of Ad vector to its natural receptor CAR. Recently, structural analysis and site-directed mutagenesis have led to the identification of key determinants of binding specificity. [19] [20] [21] In addition, Roelvink et al 18 demonstrated the feasibility of simultaneously ablating the CAR-binding site of the Ad knob and redirecting the virus to a new receptor in vitro.
In the present study, we have mutated residues involved in CAR binding that are located in the AB and DG loop of the knob domain and have produced the cognate CAR-ablated viruses. Apart from the study of Roelvink et al 18 no other data concerning the production of CAR-ablated adenovirus are available. Indeed, the recent studies which led to the identification of the CAR-binding site were performed using soluble recombinant Ad fiber proteins. [19] [20] [21] It was thus important to study the impact of fiber-genetic modifications in the viral context since the fiber, in addition to mediating binding to the cell surface, seems to play a role in the maturation of the viral particle as well as in the intracellular trafficking in infected cells. 26, 37 In contrast to the fiber-deleted virus, we have shown that the fiber-modified viruses maintain stoichiometric incorporation of the fiber protein in the viral capsid, undergo efficient proteolytic processing and are not impaired in intracellular trafficking. We have also shown that the reduced infectivity of the mutant virus can be restored in vitro by the addition of seven consecutive polylysine residues at the C-terminal end of the knob sequence thus confirming that the low infectivity was related to an impaired interaction with the cellular Ad receptor. In addition, competition experiments clearly demonstrate that the combination of the Ser408Glu mutation in the AB loop and the addition of the polylysine ligand allows high specificity retargeting towards heparan sulfate proteoglycans in vitro.
Improving current Ad vectors by a specific restriction of the viral tropism would represent a significant technological advance towards safer and more efficient gene delivery vectors. Several strategies have already been tested in vitro to selectively modify the natural Ad tropism (for review, see Ref. 38 ) but the coming challenge for targeted adenovirus vectors is the demonstration that these strategies are successful in vivo. We have studied the biodistribution of CAR-ablated mutant viruses after i.v. administration in the mouse. In agreement with published data, [32] [33] [34] [35] [36] intravenously delivered wild-type Ad was distributed to a wide variety of tissues with the great majority of the vector localized in the liver. In contrast, the PCR signal for the fiberless virus was very weak, suggesting that either these particles are unstable in the blood stream and thus rapidly cleared before they reach the organs or, as demonstrated in our laboratory (V Legrand, unpublished data), that these fiberless particles are sequestered in the endosomes of infected cells. This latter observation underscores that, in addition to mediating binding to the cell surface, the fiber plays an important role in the intracellular trafficking of the virus. 37 In addition, our results clearly demonstrate that the biodistribution of CAR-ablated viruses without addition of a specific ligand is not significantly changed as compared with i.v. administration of wild-type virus. This observation could be explained in several ways. First, the mutated knob sequence of the fiber-modified Ads may retain residual CAR-binding properties. In this case, since we administered as much as 10 11 Ad particles in mice, even 1% of residual CAR-binding particles (ie 10 9 particles) would represent significant binding to the natural receptor. However, this explanation is unlikely since a 100-fold decrease in viral DNA content would be detectable using quantitative PCR. In addition, it has already been demonstrated, using surface plasmon resonance (SPR) analysis, that the Ser408Glu-fiber protein, for example, does not display residual CAR-binding affinity. 21 Second, the ␣ v integrins may be able to mediate virus binding and uptake in the liver in the absence of CAR interactions. In support of this possibility, integrin ␣ m ␤ 2 , which is expressed on Kü pfer cells in the liver, has been shown to mediate direct binding of Ad to cells. 38 To address this issue, the construction of CAR and integrinablated vectors will be useful to evaluate liver sequestration in vivo further. Third, as Fechner et al 33 recently demonstrated, receptor-independent anatomical parameters could explain the hepatic tropism of Ad particles after systemic delivery. These authors showed that adenovirus receptor expression is necessary but not sufficient for vector transfer after i.v. injection suggesting that other factors such as vascular egress may play a key role. However, other studies have demonstrated that i.v. injected FGF2-retargeted Ad localized to the liver to a lesser extent (10-to 20-fold less) than the wild-type Ad. 39, 40 Printz et al 40 nevertheless suggested that the observed reduction in liver transduction of FGF2-Ad may be due to a reduced ability of the antibody-complexed virus to penetrate the smaller fenestrae of the mouse liver sinusoidal endothelium. On the other hand, Zinn et al, 41 who have examined the biodistribution in mice of both a 99m Tc-labeled Ad5 knob protein and a reticulo endothelial system (RES)-specific radiotracer, demonstrated that 10 min after systemic administration more than 80% of the labeled molecules could be detected in the liver. This suggests that the hepatic capture of these molecules was rapid and not Ad-specific. Finally, this latter hypothesis concerning our in vivo data would suggest that wild type as well as CAR-mutant Ad viruses would be rapidly, systematically and aspecifically sequestered in the liver, after i.v injection. This underscores the basic aspects of vascular pharmacodynamics and anatomical parameters which have not yet, until now, been clearly linked to the utility of Ad vectors in systemic delivery. Indeed, such a systematic and rapid aspecific capture of virus particles in the liver would severely handicap targeted Ad gene therapy. This seems to be confirmed since Ye et al 42 recently demonstrated that levels of transgene expression can be significantly improved in mouse lung, intestine and kidney by intravenous injection of recombinant Ad concurrent with a portal clamping to bypass the liver circulation.
Extensive experimental evidence has now established in vitro that the cellular tropism of Ad vectors can be modulated by using vectors with specific ligands immunologically coupled to, or genetically inserted in the viral capsid proteins. To illustrate in vivo targeting, it will be necessary to associate CAR-ablated adenovirus with high affinity specific ligands. The construction of CAR and integrin-ablated vectors, in association with specific ligands, will also be useful to evaluate the impact on tissue distribution in vivo. Whether these targeting strategies will succeed in avoiding a rapid sequestration of vectors in the liver after systemic administration remains to be determined.
Materials and methods
Cells
The human embryonic kidney 293 cell line (ATCC, Rockville, MD, USA) and the CHO cell line (ATCC; CCL-61) were grown at 37°C in DMEM supplemented with 10% fetal calf serum and antibiotics. 293-Fiber cells (293-Fb), which constitutively express the adenovirus type 5 fiber protein, have been described previously. 26 Construction of fiber-modified viral genomes All cloning steps were performed using standard molecular biology techniques. 43 In order to introduce mutations in Ad5 fiber knob, a mutagenesis template for the Sculptor in vitro mutagenesis system (Amersham, Les Ulis, France) was first generated. The template single-strand DNA m13F5knob contains Ad5 sequence from nucleotide (nt) 31994 (HindIII site) to nt 32991 (SmaI site). 22 The mutations were introduced with the following antisense oligonucleotides: Ser408Glu: 5Ј-gc att tag tct aca gtt agg ctc tgg agc tgg tgt ggt cca c-3Ј; Leu485Asp: 5Ј-ata ggc tgt gcc ttc agt gtc atc tcc att tct aaa gtt-3Ј; Tyr491Asp: 5Ј-aaa tcc aac agc gtt tgt gtc ggc tgt gcc ttc agt aag-3Ј; Ala494Asp: 5Ј-gtt agg cat aaa tcc aac gtc gtt tgt ata ggc tgt gcc-3Ј; Phe497Asp: 5Ј-agc tga tag gtt agg cat gtc tcc aac agc gtt tgt ata-3Ј; Met498Asp: 5Ј-ata agc tga tag gtt agg gtc aaa tcc aac agc gtt tgt-3Ј; Pro499Gly: 5Ј-tgg ata agc tga tag gtt tcc cat aaa tcc aac agc gtt-3Ј; Ala503Asp: 5Ј-acc gtg aga ttt tgg ata gtc tga tag gtt agg cat aaa-3Ј; Tyr563Ser: 5Ј-ggc aaa tat ttc att aat tga gtt gtg gcc aga cca gtc-3Ј. To add seven lysine residues (7K) and a flexible linker at the C-terminal extremity of the fiber, the single strand template (either wt or mutated m13F5knob) was mutated using oligonucleotide OTG7000 (5Ј-aac gat tct tta gct gcc ggg agc aga ggc gga ggc gga ggc gct ggg ttc ttg ggc aat-3Ј) in order to introduce a 12 amino acid linker Gene Therapy (ProSerAlaSerAlaSerAlaSerAlaProGlySer) and then with OTG12125 (5Ј-cac aaa cga tct tta ctt ctt ctt ttt tct tct ttt tgg atc cgg gag cga ggc gga g-3Ј) to add the seven lysine residues. The HindIII-SmaI fragments isolated from the mutated m13F5knob plasmids were directly introduced by homologous recombination into the BstBI-restricted pTG4213. This plasmid contains a ␤-galactosidase expressing E1-deleted Ad5 genome in which a unique BstBI site was introduced at nucleotide 32 940, downstream of the fiber stop codon. The generation of the pTG4213 was as follows: m13F5knob was mutated with OTG7213 (5Ј-t gaa aaa tga ttc gaa att ttc tgc a-3Ј) to introduce a unique BstBI site (sequence in bold). The isolated HindIII-SmaI fragment was cloned by homologous recombination in the E. coli BJ5183 recBC sbcBC strain 25 in pTG8533, a transfer plasmid bearing an Ad5 segment extending from nt 21 562 to the right-end ITR; thereafter, the purified BstEII fragment (nt 24 843-35 233) was introduced into the Ad5 genome by homologous recombination with pTG3602, a plasmid containing the fulllength Ad5 genome. 25 The replacement in this backbone of the E1 region with the MLP-␤-galactosidase expression cassette was performed as described previously. 26 Virus production and titration Five micrograms of the fiber-modified viral genomes were excised from the plasmid backbone by PacI digestion and transfected into 293 or 293-Fb cells. Cells were then recovered 2 weeks after transfection for further analysis and expansion either in wild-type 293 cells or in 293-Fb cells, depending on the required complementation. 26 Primary viral stocks were then amplified on 293 cells. Virus purification, titration and storage were as described. 44 Virus particle concentration (P/ml) was measured by optical density (of one OD 260 corresponds to 1.1 × 10 12 P/ml); infectious titers (IU/ml) were determined 16 h to 20 h after infection of 293 cells by staining for ␤-galactosidase activity. 45 The integrity of the viral genome and the presence of the fiber mutation were verified by analyzing viral DNA, extracted using the Hirt method. 46 Analysis of the adenoviral protein profile Purified viral particles (2 × 10 10 ) were diluted in 2 × Laemmli buffer, incubated for 5 min at 95°C and loaded on to a 10% SDS-polyacrylamide gel. The proteins were detected by silver staining. 47 Specific detection of the fiber or penton base proteins was performed as previously described. 26 Competition experiments Target cell monolayers were incubated for 1 h at 4°C with either PBS or competitor molecules. Wild-type or fibermodified Ad-LacZ were then added. After incubation for 24 h at 37°C, cells were fixed and stained for ␤-galactosidase activity. Alternatively, the ␤-galactosidase activity of whole cell lysate was monitored using a chemiluminescent substrate (luminescent ␤-galactosidase detection kit; Clontech, Palo Alto, CA, USA). As competitor for the normal adenoviral entry process, purified Ad5 knob (10 g/ml) 26 or RGD peptide (4 mg/ml; Neosystem, Strasbourg, France) were used. As inhibitor of heparan sulfate proteoglycan binding, heparin (3 mg/ml, Sigma, Saint Quentin Fallavier, France) was used as previously described.
Gene Therapy
Animal experiments C57Bl/6 mice were injected intravenously in the tail vein with 10 11 particles of either wild-type or fiber-modified virus. Animals were killed after 48 h and total DNA was extracted, as previously described 44 from different organs (spleen, liver, heart and lung) for quantitative PCR assays. To detect expression of the transgene, pieces of the liver were snap-frozen, ground and lysed in 1 × RLB buffer (Promega, Lyon, France). After three cycles of freezing-thawing, the lysates were centrifugated at 13 000 r.p.m. for 15 min at 4°C. ␤-Galactosidase activity of the supernatant was measured using the Luminescent Detection Kit (Clontech). The protein content of the lysate was monitored in parallel using the BCA Protein Assay Reagent kit (Pierce, Rockford, IL, USA).
Quantitative PCR analysis of Ad DNA To quantify the amount of Ad genomic DNA in the different recovered organs after intravenous injection, Ad DNA and murine ␤-actin DNA were analyzed by realtime PCR (TaqMan PCR detection; Perkin Elmer (PE) Applied Biosystems, Foster City, CA, USA). 48 The Ad IVa2 sequence and the murine ␤-actin gene were amplified and quantified by TaqMan PCR from 1 g of total DNA of each recovered organ. A fluorigenic probe (TGACCTCCAAGATTTTCCATGCATTCG) was designed to anneal to the target between the sense primer (GAACCACCAGCACAGTGTATCC) and the antisense primer (GGCCCATTGCCATCATTATG) in the IVa2 region of the Ad genome. The fluorogenic probe contains a reporter dye (6-carboxyfluorescein; 5Ј end) and a quencher dye (6-carboxy-N, N, NЈ, NЈ-tetramethylrhodamine; 3Ј end). During the extension phase of the PCR cycle, the 5Ј-3Ј exonuclease activity of the Taq polymerase cleaves the hybridized fluorigenic probe, resulting in an increase in fluorescence emission from the reporter dye that quantitatively reports the amount of PCR product. Sample were amplified for 40 cycles in a PE model 570 sequence detection system with continuous monitoring of the fluorescence. Data were processed by the SDS 1.6 software package (PE). For murine ␤-actin detection, ␤-actin primers and probe were used, as previously described. 49 To correct for differences in DNA recovery from samples, the data are presented as the ratio of Ad genome copies to ␤-actin DNA copies.
